Paul Hastings Biography

Mr. Hastings has been the President and Chief Executive Officer of QLT Inc. Previous to that Mr. Hastings served as President and Chief Executive Officer of Axys Pharmaceuticals which was acquired by Celera Corporation in 2001. From 1999 to 2001 Mr. Hastings served as the President of Chiron BioPharmaceuticals a division of Chiron Corporation. Prior to that he was President and Chief Executive Officer of LXR Biotechnology. Mr. Hastings also held a series of management positions of increasing responsibility at Genzyme Corporation including serving as President of Genzyme Therapeutics Europe as well as President Genzyme Therapeutics. Mr. Hastings also served as Vice President Marketing and Sales and General Manager Europe for Synergen Inc. and previously held a series of marketing and sales management positions with Hoffmann-La Roche. Mr. Hastings was recently Chairman of the Board of Proteolix (sold to Onyx Pharmaceuticals in 2010) and served on the boards of ViaCell (sold to Perkin-Elmer in 2007).

As a renowned expert and highly sought-after speaker, Paul Hastings's expertise is in high demand. To book Paul Hastings for your next event, conference, or workshop, please contact our speaker booking agency. Our experienced team will work closely with you to understand your specific needs and help secure Paul Hastings's participation. With our professional guidance and seamless booking process, you can ensure a memorable and impactful experience for your audience. Don't miss the opportunity to engage your audience with Paul Hastings's compelling insights and inspire positive change within your organization. Fill out the booking request form to take the first step in securing Paul Hastings for your next speaking engagement.